Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-08-22
2008-10-28
Campell, Bruce (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C514S183000, C424S159100, C424S178100
Reexamination Certificate
active
07442380
ABSTRACT:
A method of prophylactic and/or therapeutic treatment of a mammal for a disease that is caused by a Ljungan virus infection, such as Myocarditis, Cardiomyopathia, Guillain Barré Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis, Amyothrophic Lateral Sclerosis, Dermatomyositis, Polymyositis, Spontaneous Abortion, Intrauterine Death, Preeclampsia, Sudden Infant Death Syndrome, Bell's (facial) paralysis, Addison's disease, and Pernicious anemia, is described. An antiviral compound effective against a Ljungan virus, such as a compound effective against a picornavirus, e.g. Pleconaril or a derivative thereof, is used for the preparation of a medicament for the treatment of a disease in a mammal that is caused by a Ljungan virus infection, to eliminate or inhibit proliferation of the virus in the mammal and at the same time prevent and/or treat the disease in the mammal. A composition for treatment of a mammal for a disease caused by Ljungan virus infection including an antiviral compound, antiserum, and an interferon. A method of treatment of a mammal for a disease caused by a Ljungan virus infection.
REFERENCES:
patent: 7101554 (2006-09-01), Niklasson
patent: 2004/0265793 (2004-12-01), Niklasson et al.
patent: 2005/0233311 (2005-10-01), Lindberg et al.
patent: WO 98/11133 (1998-03-01), None
Haverkos et al., Enteroviruses and Type 1 diabetes mellitus, 2003, Biomedicine and Pharmacotherapy, vol. 57, pp. 379-385.
Honeyman M., How robust is the evidence for viruses in the induction of type 1 diabetes, 2005. Current Opinion of Immunology, vol. 17, pp. 616-623.
Lammi et al., Do microbes have a causal role in type 1 diabetes?, 2005, Medical Science Monitor, vol. 11, No. 3, pp. 63-69.
Moscatiello et al., Diabetes and liver disease: An ominous association, 2007, Nutrition, Metabolism and Cardiovascular Diseases, vol. 17, pp. 63-70.
Szopa et al., Diabetes Mellitus due to viruses-some recent developments, 1993, Diabetologia, vol. 36, pp. 687-695.
Yoon et al., Viruses Cause Type 1 Diabets in Animals, 2006, Annals New York Academy of Sciences, vol. 1079, pp. 138-146.
Roep et al., Are Insights Gained from NOD mice Sufficient to Guide Clinical Translation?, Another Inconvenient Truth, 2007, Annals of the New York Academy of Sciences, vol. 1103, pp. 1-10.
Tauriainen et al., Human Parechovirus 1 Infections in Young Children-No Association With Type 1 Diabetes, 2007, Journal of Medical Virology, 2007, vol. 79, pp. 457-462.
Niklasson, B., et al. Could Myocarditis, Insulin-Dependent Diabetes Mellitus, and Guillain-Barre Syndrome Be Caused by One or More Infectious Agents Carried by Rodents?, Emerging Infectious Diseases, vol. 4, No. 2, Apr.-Jun. 1998.
Niklass, B., et al. A New Picomavirus Isolated from Bank Voles (Clethrionomys glareolus), Virology 255, 86-93 (1999).
Rotbart, H, et al. Treatment of Potentially Life-Threatening Enterovirus Infections with Pleconaril, CID 2001:32 (Jan. 15).
Rotbart H. Treatment of picomavirus infections, Antiviral Research 52 (2002) 83-98.
Stanway, G., Human parechoviruses-biology and clinical significance, Rev. Med. Virol. 2000; 10: 57-69.
Apodemus AB
Blumel Benjamin P
Campell Bruce
Kohn Kenneth I.
Kohn & Associates PLLC
LandOfFree
Treatment of diseases caused by viral infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of diseases caused by viral infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases caused by viral infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4002079